Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
| Image |  |
|---|---|
| Description | scientific article published in May 2004 |
| Author/s |
author: Ingunn Holen Peter I Croucher |
| Publication date | May 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |